NEW YORK & BOSTON--(BUSINESS WIRE)--Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity therapeutics, today announced an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results